forward-pharm.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
Meta Tags
| Title | Forward-Pharm |
| Description | JOHN TALLEY, About Us Pipeline News Join Us Contact Us 中 EN About Us --> Pipeline --> News Company News Industry News --> Join Us --> Contact Us --> TEC |
| Keywords | Forward-Pharm |
Server Information
| WebSite | |
| Host IP | 47.106.247.150 |
| Location | Canada |
Related Websites
| Site | Rank |
More to Explore
forward-pharm.com Valuation
|
US$421,201
Last updated: 2023-05-17 03:11:11
forward-pharm.com has Semrush global rank of 25,128,902. forward-pharm.com has an estimated worth of US$ 421,201, based on its estimated Ads revenue. forward-pharm.com receives approximately 48,601 unique visitors each day. Its web server is located in Canada, with IP address 47.106.247.150. According to SiteAdvisor, forward-pharm.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$421,201 |
| Daily Ads Revenue | US$389 |
| Monthly Ads Revenue | US$11,665 |
| Yearly Ads Revenue | US$139,969 |
| Daily Unique Visitors | 3,241 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| forward-pharm.com. | A | 600 | IP: 47.106.247.150 |
| forward-pharm.com. | NS | 21600 | NS Record: dns13.hichina.com. |
| forward-pharm.com. | NS | 21600 | NS Record: dns14.hichina.com. |
| forward-pharm.com. | MX | 600 | MX Record: 5 mxn.mxhichina.com. |
| forward-pharm.com. | MX | 600 | MX Record: 10 mxw.mxhichina.com. |
| forward-pharm.com. | TXT | 600 | TXT Record: MS=ms26668220 |
| forward-pharm.com. | TXT | 600 | TXT Record: v=spf1 include:spf.mxhichina.com -all |
HtmlToTextCheckTime:2023-05-17 03:11:11
| About Us Pipeline News Join Us Contact Us 中 EN About Us --> Pipeline --> News Company News Industry News --> Join Us --> Contact Us --> TECHNOLOGY DRIVES DRUG INNOVATION contact us --> Innovation Platform JOHN TALLEY, Ph.D. JOHN TALLEY, Ph.D. Chief Scientific Advisor Dr. John Talley, the Chief Scientific Advisor for Forward, is one of the world’s most successful medicinal chemists, bringing over 30 years of industry experience to the R&D team. He is the inventor of Celebrax (celecoxib), Pfizer’s blockbuster product-COX-2 inhibitor, which has generated cumulative sales of over $50 billion for Pfizer. Other drugs including Dynastat (parecoxib) and Bextra were also subsequently invented by him. In addition, Dr. Talley has led the development of the HIV protease inhibitors Agenerase, Lexiva and Prezista. During his career, Dr. John Talley has invented 8 new drugs that have been marketed worldwide, and has several subsequent drugs still in development. Dr. Talley served |
HTTP Headers
HTTP/1.1 200 OK Cache-Control: private Content-Length: 40511 Content-Type: text/html; charset=utf-8 Server: Microsoft-IIS/7.5 Set-Cookie: ASP.NET_SessionId=zwytedjnhu1fkmdixbh2ulu5; path=/; HttpOnly X-Powered-By: ezEIP X-Frame-Options: SAMEORIGIN Date: Thu, 03 Mar 2022 08:16:59 GMT |
forward-pharm.com Whois Information
Domain Name: FORWARD-PHARM.COM Registry Domain ID: 2159593030_DOMAIN_COM-VRSN Registrar WHOIS Server: grs-whois.hichina.com Registrar URL: http://www.net.cn Updated Date: 2020-08-24T06:11:53Z Creation Date: 2017-09-04T11:09:50Z Registry Expiry Date: 2022-09-04T11:09:50Z Registrar: Alibaba Cloud Computing (Beijing) Co., Ltd. Registrar IANA ID: 420 Registrar Abuse Contact Email: DomainAbuse@service.aliyun.com Registrar Abuse Contact Phone: +86.95187 Domain Status: ok https://icann.org/epp#ok Name Server: DNS13.HICHINA.COM Name Server: DNS14.HICHINA.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-03T08:41:43Z <<< |